Literature DB >> 9700651

Evolution of neuronal changes in the course of Alzheimer's disease.

H Braak1, E Braak.   

Abstract

Alzheimer's disease entails multiple neuronal systems and results from neuronal cytoskeletal degeneration of only a few types of nerve cells. Essential for neuropathological diagnosis is assessment of the presence of neurofibrillary tangles and neuropil threads. The destructive process begins in predisposed cortical induction sites, thereafter invading other portions of the cerebral cortex and specific sets of subcortical nuclei in a predictable sequence with little variation. The location of the tangle-bearing neurons and severity of the pathology allow the distinction of six stages in disease propagation (transentorhinal I-II: clinically silent cases; limbic III-IV: incipient Alzheimer's disease; neocortical V-VI: fully-developed Alzheimer's disease). The pattern of appearance of the neurofibrillary changes bears a striking resemblance to the inverse sequence of cortical myelination. The average myelin content is a negative image of the density of intraneuronal lipofuscin deposits. Pigment-laden neurons endowed with a long, thin, and sparsely myelinated axon are prone to develop AD-related changes. The emergence of the first neurofibrillary changes, at whatever age these occur, signals the onset of a degenerative process that persists until death. An extended period of time elapses between the beginning of histologically verifiable lesions and the appearance of initial clinical symptoms. Once initiated, however, cytoskeletal deterioration inexorably progresses, and neither remission nor recovery is observed.

Entities:  

Mesh:

Year:  1998        PMID: 9700651     DOI: 10.1007/978-3-7091-6467-9_11

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  135 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Past glory and future promise: maximizing and improving understanding of atrophy patterns in the diagnosis of degenerative dementias.

Authors:  Bruce L Miller
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

3.  CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease.

Authors:  Michael R Sierks; Gaurav Chatterjee; Claire McGraw; Srinath Kasturirangan; Philip Schulz; Shalini Prasad
Journal:  Integr Biol (Camb)       Date:  2011-11-10       Impact factor: 2.192

4.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

5.  Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype.

Authors:  J Cervilla; M Prince; S Joels; S Lovestone; A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 6.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

7.  Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

Authors:  C K Combs; D E Johnson; J C Karlo; S B Cannady; G E Landreth
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

8.  Therapeutic application of melatonin in mild cognitive impairment.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Analía M Furio; Luis I Brusco
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

10.  Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease.

Authors:  Mark Kilgore; Courtney A Miller; Daniel M Fass; Krista M Hennig; Stephen J Haggarty; J David Sweatt; Gavin Rumbaugh
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.